212 related articles for article (PubMed ID: 9153656)
41. GABA and GABAA receptor changes in the substantia nigra of the rat following quinolinic acid lesions in the striatum closely resemble Huntington's disease.
Nicholson LF; Faull RL; Waldvogel HJ; Dragunow M
Neuroscience; 1995 Jun; 66(3):507-21. PubMed ID: 7644016
[TBL] [Abstract][Full Text] [Related]
42. AMP-activated protein kinase slows D2 dopamine autoreceptor desensitization in substantia nigra neurons.
Yang W; Munhall AC; Johnson SW
Neuropharmacology; 2019 Nov; 158():107705. PubMed ID: 31301335
[TBL] [Abstract][Full Text] [Related]
43. Opposing roles of dopamine D1 and D2 receptors in nigral gamma-[3H]aminobutyric acid release?
Starr M
J Neurochem; 1987 Oct; 49(4):1042-9. PubMed ID: 2957468
[TBL] [Abstract][Full Text] [Related]
44. Activation of D1 receptors stimulates accumulation of gamma-aminobutyric acid in slices of the pars reticulata of 6-hydroxydopamine-lesioned rats.
Aceves J; Floran B; Martinez-Fong D; Benitez J; Sierra A; Flores G
Neurosci Lett; 1992 Sep; 145(1):40-2. PubMed ID: 1461565
[TBL] [Abstract][Full Text] [Related]
45. GABAergic control of substantia nigra dopaminergic neurons.
Tepper JM; Lee CR
Prog Brain Res; 2007; 160():189-208. PubMed ID: 17499115
[TBL] [Abstract][Full Text] [Related]
46. Repeated D1 dopamine receptor agonist administration prevents the development of both D1 and D2 striatal receptor supersensitivity following denervation.
Hu XT; White FJ
Synapse; 1992 Mar; 10(3):206-16. PubMed ID: 1532677
[TBL] [Abstract][Full Text] [Related]
47. Dopamine receptor subtypes colocalize in rat striatonigral neurons.
Surmeier DJ; Eberwine J; Wilson CJ; Cao Y; Stefani A; Kitai ST
Proc Natl Acad Sci U S A; 1992 Nov; 89(21):10178-82. PubMed ID: 1332033
[TBL] [Abstract][Full Text] [Related]
48. GABAergic afferents activate both GABAA and GABAB receptors in mouse substantia nigra dopaminergic neurons in vivo.
Brazhnik E; Shah F; Tepper JM
J Neurosci; 2008 Oct; 28(41):10386-98. PubMed ID: 18842898
[TBL] [Abstract][Full Text] [Related]
49. Hypoglycemia enhances ionotropic but reduces metabotropic glutamate responses in substantia nigra dopaminergic neurons.
Marinelli S; Federici M; Giacomini P; Bernardi G; Mercuri NB
J Neurophysiol; 2001 Mar; 85(3):1159-66. PubMed ID: 11247985
[TBL] [Abstract][Full Text] [Related]
50. Nigral GABAergic inhibition upon mesencephalic dopaminergic cell groups in rats.
Saitoh K; Isa T; Takakusaki K
Eur J Neurosci; 2004 May; 19(9):2399-409. PubMed ID: 15128394
[TBL] [Abstract][Full Text] [Related]
51. N-methyl-D-aspartate receptor blockade differentially modifies regional cerebral metabolic responses to D1 and D2 dopamine agonists in rats with a unilateral 6-hydroxydopamine lesion.
Engber TM; Anderson JJ; Boldry RC; Kuo S; Chase TN
Neuroscience; 1993 Jun; 54(4):1051-61. PubMed ID: 8101981
[TBL] [Abstract][Full Text] [Related]
52. Distinct mechanisms of presynaptic inhibition at GABAergic synapses of the rat substantia nigra pars compacta.
Giustizieri M; Bernardi G; Mercuri NB; Berretta N
J Neurophysiol; 2005 Sep; 94(3):1992-2003. PubMed ID: 15944237
[TBL] [Abstract][Full Text] [Related]
53. The GABA and substance P input to dopaminergic neurones in the substantia nigra of the rat.
Bolam JP; Smith Y
Brain Res; 1990 Oct; 529(1-2):57-78. PubMed ID: 1704287
[TBL] [Abstract][Full Text] [Related]
54. Dopamine D1 receptors facilitate GABAA synaptic currents in the rat substantia nigra pars reticulata.
Radnikow G; Misgeld U
J Neurosci; 1998 Mar; 18(6):2009-16. PubMed ID: 9482788
[TBL] [Abstract][Full Text] [Related]
55. Physiological properties of zebra finch ventral tegmental area and substantia nigra pars compacta neurons.
Gale SD; Perkel DJ
J Neurophysiol; 2006 Nov; 96(5):2295-306. PubMed ID: 16870835
[TBL] [Abstract][Full Text] [Related]
56. Gabaergic transmission and tyrosine hydroxylase expression in the nigral dopaminergic neurons: an in vivo study using a reversible ischemia model of rats.
Yamada K; Goto S; Yoshikawa M; Ushio Y
Neuroscience; 1996 Aug; 73(3):783-9. PubMed ID: 8809797
[TBL] [Abstract][Full Text] [Related]
57. Effects of intrasubthalamic injection of dopamine receptor agonists on subthalamic neurons in normal and 6-hydroxydopamine-lesioned rats: an electrophysiological and c-Fos study.
Hassani OK; Féger J
Neuroscience; 1999; 92(2):533-43. PubMed ID: 10408602
[TBL] [Abstract][Full Text] [Related]
58. Localization of GABA transaminase immunoreactivity in the rat substantia nigra pars reticulata.
Yung KK; Tse YC; Gao ZG; Choi SY; Kwok FS
Neurosci Lett; 1998 Aug; 253(1):57-60. PubMed ID: 9754804
[TBL] [Abstract][Full Text] [Related]
59. Effects of full D1 dopamine receptor agonists on firing rates in the globus pallidus and substantia nigra pars compacta in vivo: tests for D1 receptor selectivity and comparisons to the partial agonist SKF 38393.
Ruskin DN; Rawji SS; Walters JR
J Pharmacol Exp Ther; 1998 Jul; 286(1):272-81. PubMed ID: 9655869
[TBL] [Abstract][Full Text] [Related]
60. Molecular anatomy of the development of the human substantia nigra.
Aubert I; Brana C; Pellevoisin C; Giros B; Caille I; Carles D; Vital C; Bloch B
J Comp Neurol; 1997 Mar; 379(1):72-87. PubMed ID: 9057113
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
